The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial..
Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up..
J Am Coll Cardiol, 31 , pp. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.. Am Heart J, , pp. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism..
Management of unsuccessful thrombolysis in acute massive pulmonary embolism.. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach.. J Thorac Cardiovasc Surg, , pp. Mechanical catheter intervention in massive pulmonary embolism: proof of concept.. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism..
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.. Circulation, 77 , pp.
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? Thromb Haemost.. Chest, Suppl , pp. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.
American-Canadian Thrombosis Study Group.. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin..
J Thromb Thrombolysis, 21 , pp. Management of massive pulmonary embolism.. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction.. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism..
Heart, 77 , pp. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate.. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review.. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism.. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism..
Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.. Prognostic role of brain natriuretic peptide in acute pulmonary embolism..
BE Medline. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism.. Eur Respir J, 22 , pp. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism.. DB Medline. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis..
N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.. Differential diagnosis of elevated troponins.. Heart, 92 , pp. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis..
Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis..
The fatty acid transport function of fatty acid-binding proteins.. Biochim Biophys Acta, , pp. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.. Eur Heart J, 28 , pp. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism..
Clin Chim Acta, , pp. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism.. Growth differentiation factor for prognostic assessment of patients with acute pulmonary embolism.. Validation of a model to predict adverse outcomes in patients with pulmonary embolism.. Eur Heart J, 27 , pp.
Derivation and validation of a prognostic model for pulmonary embolism.. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy.. Natural history of venous thromboembolism.. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism.. Thromb Haemost, 88 , pp. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study..
The long-term clinical course of acute deep venous thrombosis.. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.. D-dimer testing to determine the duration of anticoagulation therapy..
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis..
Bleeding with anticoagulation therapy?? Clinical outcome of patients with major bleeding after venous thromboembolism. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.. Venous thromboembolism and cancer: risks and outcomes.. Chronic thromboembolic pulmonary hypertension.. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism..
Proc Am Thorac Soc, 3 , pp. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.. Fibrinogen alpha ThrAla polymorphism is associated with chronic thromboembolic pulmonary hypertension.. Eur Respir J, 31 , pp. Eur Respir J, 23 , pp. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension..
Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Lung scintigraphy in pulmonary capillary hemangiomatosis.
A rare disorder causing primary pulmonary hypertension.. Clin Nucl Med, 16 , pp. Large vessel pulmonary arteritis mimicking chronic thromboembolic disease.. Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings.. Palabras clave:.
Pulmonary embolism; Review; Interventional therapy; medical treatment; Mexico. Texto completo. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry.. Pulmonary embolism as a cause of death in patients with heart disease.. An autopsy study. Una alternativa en casos seleccionados. Urgencias Cardiovasculares. Hemodynamic effects of fluid loading in acute massive pulmonary embolism..
Managemenet of massive pulmonary embolism.. Volume expansion cersus norepinephrine in treatment of a low cardiac output complicating in acute increase in right ventricular afterload in dogs.. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure..
Dobutamine: a hemodynamic evaluation in pulmonary embolism shock.. Influence of cardiac output on oxygen exchange in acute pulmonary embolism.. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial.. Guidelines on the diagnosis and management of acute pulmonary embolism..
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but susceptible to inactivation by antithrombin III-independent inhibitors.. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis..
Randomized trial of sub-cutaneous low-molecular-weight heparin CY Fraxiparine compared with intravenous unfractioned heparin in the curative treatment of submassive pulmonary embolism.. A dose-ranging study. A comparison of low-molecular-weight heparin with unfractioned heparin for acute pulmonary embolism.
Cuenta con ocho variables y cada una tiene un valor. Su utilidad radica en observar otros hallazgos que orienten hacia un problema diferente. Figura 1. Ciertos hallazgos son de utilidad para que el examinador tenga un alto grado de sospecha.
Figura 2. Electrocardiograma de un paciente con TEP. En la figura A se aprecia el trazo en condiciones basales. Divide a los pacientes en riesgo alto, intermedio o bajo. El algoritmo a seguir en el paciente con sospecha de TEP, se muestra en la Figura 3.
Figura 3. Ante un paciente con sospecha de TEP primero se debe evaluar la gravedad del mismo. Una vez confirmada la TEP el siguiente paso es ofrecer alguna forma de tratamiento. Figura 4. En la figura A se observa un trombo segmentario en ramas de la arteria pulmonar derecha. Figura 5. Gammagrama pulmonar. Estudio con probabilidad intermedia para TEP.
Figura 6. Es imperativo en todo paciente en que se sospeche TEP, efectuar cualquiera de los puntajes de Wells o Geneva y clasificarlo de acuerdo a la probabilidad en baja, intermedia o alta. Correspondencia: Jaime Eduardo Morales Blanhir. CP Recibido el 24 de mayo de ; aceptado el 13 de abril de Insuficiencia Cardiaca. Diagnosis of pulmonary thromboembolism. Descargar PDF. Ciudad de M??
0コメント